Basic info
Industry
biotechnology research
Sectors
Biotechnology
R&D
biotechnology
drug discovery
drug development
Pharmaceutical
oncology
Date founded
2018
Funding rounds raised
Total raised
$30M
from 6 investors over 6 rounds
M
Mablink Bioscience raised $30M on October 14, 2022
Investors: Sofinnova Partners and Merieux Equity Partners
M
Mablink Bioscience raised $4.8M on April 27, 2021
Investors: Pertinence Invest SAS, Fournier-Majoie Foundation, SHAM and Elaia